Quantcast

Latest Cutaneous lupus erythematosus Stories

2014-05-19 08:28:15

HERZLIYA, Israel, May 19, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, today announced the appointment of consultants Lee S. Simon, MD, FACP, FACR and David Isenberg, MD, for the planned Phase II trial for the Company's hCDR1 compound for the treatment of...

2014-05-13 08:31:54

SHENZHEN, China, May 13, 2014 /PRNewswire/ -- Chinese researchers have recently published new findings in Arthritis Research & Therapy, a top peer-reviewed journal in the field of systemic autoimmune rheumatic diseases, regarding the safety and effectiveness of umbilical cord (UC) derived mesenchymal stem cells (MSCs) in treating 40 patients with severe and refractory Systemic Lupus Erythematosus (SLE). The recent forty patient multi-center study was undertaken to assess the...

2014-05-10 16:21:04

NEW YORK, May 10, 2014 /PRNewswire/ -- S.L.E. Lupus Foundation's Young Leaders took Lupus Research to the Power of 10 in recognition of World Lupus Awareness Day May 10. A Flash Mob of volunteer dancers brought attention to lupus among hundreds of visitors to Union Square Park in Manhattan. Join our Power of 10 awareness program. Share this link (www.powerof10.lupusny.org) with 10 people, and ask those 10 to do the same. The goal is for 1 million people to learn about lupus and...

2014-05-05 08:30:03

- Significant clinical response to Acthar was observed in patients experiencing active disease while on conventional SLE maintenance therapies - ANAHEIM, Calif., May 5, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that results from the first modern clinical study examining the use of H.P. Acthar® Gel (repository corticotropin injection) in systemic lupus erythematosus (SLE) has been published in the journal LUPUS. This independent investigator-initiated...

2014-05-01 12:32:27

May Lupus Research Awareness Month Campaign Aims to Enlist 1 Million To Work For a World Without Lupus NEW YORK, May 1, 2014 /PRNewswire/ -- To recognize World Lupus Day, May 10, the Lupus Research Institute (LRI) asks supporters to "Take Lupus Research to the Power of 10" and help create a World Without Lupus. The new awareness program harnesses the exponential power of worldwide participation to accelerate scientific discoveries that lead to new treatments and a cure. Throughout May Lupus...

2014-04-28 23:03:54

According to a new report from BCC Research, the global market for drugs to treat systemic lupus erythematosus (SLE), is expected to grow to $2.6 billion by 2018, with a five-year compound annual growth rate (CAGR) of 22.4%. The North American market, the fastest growing regional segment overall, is growing at a tremendous 24.7% CAGR. Wellesley, Mass., (PRWEB) April 28, 2014 BCC Research (http://www.bccresearch.com) reveals in its new report, DRUGS FOR TREATING SYSTEMIC LUPUS...

2014-04-28 16:27:23

Project Runway's Tim Gunn Joins 400 NYC Leaders at S.L.E. Lupus Foundation's Annual Bag Ladies Luncheon NEW YORK, April 28, 2014 /PRNewswire/ -- Hundreds of leaders in New York's fashion, entertainment, travel, philanthropic and lupus communities turned out to support the fight against lupus at the S.L.E. Lupus Foundation's sixth annual New York Bag Ladies Luncheon. Raising over $350,000, the sold-out event featured Emmy-winning Project Runway host Tim Gunn as Master of Ceremonies....

2014-04-03 08:27:41

Lupus Science & Medicine is launched to provide the latest lupus research and stimulate collaborative efforts to improving the lives of all people affected by lupus WASHINGTON, April 3, 2014 /PRNewswire-USNewswire/ -- The Lupus Foundation of America and BMJ announced today the launch and publication of the first scientific research articles in Lupus Science & Medicine(TM). Lupus Science & Medicine is a peer reviewed, Open Access, online journal that provides a central point for...

2014-03-25 08:29:48

HERZLIYA, Israel, March 25, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"), a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of unmet clinical needs, today announced the appointment of Daniel J. Wallace, MD and Murray Urowitz, MD, two experts in rheumatology, as consultants for the planned Phase II trial for the Company's hCDR1...

2014-03-18 23:02:43

Discounted research study “PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022” elaborated by GlobalData is now available at MarketPublishers.com. According to the report, new product launches are set to fuel SLE and LN treatment markets expansion through to 2022. London, UK (PRWEB) March 18, 2014 The systemic Lupus Erythematosus (SLE) treatment market in the 7 major nations (the US, Germany, France, the UK, Italy, Japan,...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related